Traditionally, trans people take hormones in high enough amounts to produce drastic changes right away. But microdosing ...

Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Anti-androgens may be beneficial for managing certain ...

Peter Salgo, MD, and Ira M. Klein, MD, MBA, FACP, discuss heterogeneous tumors in prostate cancer, the utilization of combination regimens, and the need for additional research within the field. Dr ...

Source: Getty Images Prostate cancer patients treated with second-generation antiandrogens may have an increased risk of falls, fatigue, and cognitive toxicity. Prostate cancer patients treated with ...

Male-to-female (MTF) hormone therapy, or estrogen hormone therapy, is a treatment that some people may receive in order to induce “feminine” physical traits and suppress “masculine” ones. This may ...

The increasing number of indications for second-generation antiandrogens may result in a large group of men at risk for toxic effects, according to investigators. Second-generation antiandrogens have ...

Second-generation antiandrogens (AAs) ― abiraterone, apalutamide, darolutamide, and enzalutamide ― are a cornerstone of modern prostate cancer treatment, improving outcomes and survival. However, they ...

Anti-androgen therapy is commonly used to treat patients with advanced prostate cancer at stages where the disease has spread to the bones. However, new research has found that anti-androgen treatment ...

Characteristics of disease course in patients with locally advanced primarily inoperable HER2-negative breast cancer. This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This ...

Utilization of patient-reported outcomes to assess adherence to relugolix when combined with radiation therapy. Neoadjuvant darolutamide plus androgen deprivation therapy for high-risk/very high-risk ...